Crossref journal-article
Springer Science and Business Media LLC
Nature Immunology (297)
Authors 3
  1. Robert J. Binder (first)
  2. David K. Han (additional)
  3. Pramod K. Srivastava (additional)
References 35 Referenced 549
  1. Bevan, M.J. Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182, 639–641 (1995). (10.1084/jem.182.3.639) / J. Exp. Med. by MJ Bevan (1995)
  2. Suto, R. & Srivastava, P.K. A mechanism for the specific immunogenicity of heat shock protein - chaperoned peptides. Science 269, 1585–1588 ( 1995). (10.1126/science.7545313) / Science by R Suto (1995)
  3. Srivastava, P.K., Ménoret, A., Basu, S., Binder, R.J. & McQuade, K.L. Heat Shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8, 657–665 ( 1998). (10.1016/S1074-7613(00)80570-1) / Immunity by PK Srivastava (1998)
  4. Ishii, T. et al. Isolation of MHC class I – restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96 . J. Immunol. 162, 1303– 1309 (1999). (10.4049/jimmunol.162.3.1303) / J. Immunol. by T Ishii (1999)
  5. Nieland, J.D. et al. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proc. Natl Acad. Sci. USA 95, 1800–1805 (1998). (10.1073/pnas.95.4.1800) / Proc. Natl Acad. Sci. USA by JD Nieland (1998)
  6. Arnold, D., Faath, S., Rammensee, H. & Schild, H. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182, 885–889 (1995). (10.1084/jem.182.3.885) / J. Exp. Med. by D Arnold (1995)
  7. Breloer, M., Marti, T., Fleischer, B. & von Bonin, A. Isolation of processed, H-2Kb-binding ovalbumin-derived peptides associated with the stress proteins HSP70 and gp96. Eur. J. Immunol. 28, 1016–1021 (1998). (10.1002/(SICI)1521-4141(199803)28:03<1016::AID-IMMU1016>3.0.CO;2-G) / Eur. J. Immunol. by M Breloer (1998)
  8. Ménoret, A. & Srivastava, P.K. Association of peptides with the heat shock protein gp96 occurs in vivo and is not a post-cell lysis event. Biochem. Biophys. Res. Commun. 262, 813–818 (1999). (10.1006/bbrc.1999.1306) / Biochem. Biophys. Res. Commun. by A Ménoret (1999)
  9. Tamura, Y., Peng, P., Liu, K., Daou, M. & Srivastava, P.K. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278, 117–120 (1997). (10.1126/science.278.5335.117) / Science by Y Tamura (1997)
  10. Blachere, N.E. et al. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186, 1183– 1406 (1997). (10.1084/jem.186.8.1315) / J. Exp. Med. by NE Blachere (1997)
  11. Udono, H., Levey, D.L. & Srivastava, P.K. Cellular requirements for tumor - specific immunity elicited by heat shock proteins: Tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc. Natl Acad. Sci. USA 91, 3077–3081 (1994). (10.1073/pnas.91.8.3077) / Proc. Natl Acad. Sci. USA by H Udono (1994)
  12. Srivastava, P.K., Udono, H., Blachere, N.E. & Li, Z. Heat shock proteins transfer peptides during antigen processing and CTL priming . Immunogenetics 39, 93– 98 (1994). (10.1007/BF00188611) / Immunogenetics by PK Srivastava (1994)
  13. Binder, R.J., Ménoret, A. & Srivastava, P.K. Receptor-dependent and receptor-independent re-presentation of heat-shock protein-chaperoned peptides. Cell Stress Chap. 3, 2 (1998). / Cell Stress Chap. by RJ Binder (1998)
  14. Arnold-Schild, D. et al. Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells. J. Immunol. 162, 3757–3760 ( 1999). (10.4049/jimmunol.162.7.3757) / J. Immunol. by D Arnold-Schild (1999)
  15. Wassenberg, J.J., Dezfulian, C. & Nicchitta, C.V. Receptor mediated and fluid phase pathways for internalization of the ER Hsp90 chaperone GRP94 in murine macrophages. J. Cell Sci. 112, 2167–2175 ( 1999). (10.1242/jcs.112.13.2167) / J. Cell Sci. by JJ Wassenberg (1999)
  16. Singh-Jasuja, H. et al. Cross-Presentation of Glycoprotein 96-associated Antigens on Major Histocompatibility Complex Class I Molecules Requires Receptor-mediated Endocytosis. J. Exp. Med. 191, 1965– 1974 (2000). (10.1084/jem.191.11.1965) / J. Exp. Med. by H Singh-Jasuja (2000)
  17. Binder, R.J., Harris, M., Menoret, A. & Srivastava, P.K. Saturation, competition and specificity in interaction of heat shock proteins gp96, hsp90 and hsp70 with CD11b+ cells. J. Immunol. (2000) (in the press). (10.4049/jimmunol.165.5.2582)
  18. Binder, R.J., Basu, S, Anderson, K.M. & Srivastava, P.K. RAW264.7 but not RAW309Cr.1 cells can re-present HSP-chaperoned peptides. J. Immunol. (2000) (submitted).
  19. Huang, A.Y. et al. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc. Natl Acad. Sci. USA 93, 9730–9735 (1996). (10.1073/pnas.93.18.9730) / Proc. Natl Acad. Sci. USA by AY Huang (1996)
  20. Strickland, D.K. et al. Sequence identity between the α2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem. 265, 17401–17404 (1990). (10.1016/S0021-9258(18)38172-9) / J. Biol. Chem. by DK Strickland (1990)
  21. Kristensen, T. et al. Evidence that the newly cloned low-density-lipoprotein receptor related protein (LRP) is the α2-macroglobulin receptor. FEBS Lett. 276, 151–155 (1990). (10.1016/0014-5793(90)80530-V) / FEBS Lett. by T Kristensen (1990)
  22. Van Leuven, F. et al. Molecular cloning and sequencing of the murine α 2-macroglobulin receptor cDNA. Biochim. Biophys. Acta 1173, 71–74 (1993). (10.1016/0167-4781(93)90244-8) / Biochim. Biophys. Acta by F Van Leuven (1993)
  23. O'Connor-McCourt, M.D. & Wakefield, L.M. Latent transforming growth factor β in serum: a specific complex with α2-macroglobulin . J. Biol. Chem. 262, 14090– 14099 (1987). (10.1016/S0021-9258(18)47909-4) / J. Biol. Chem. by MD O'Connor-McCourt (1987)
  24. Huang, J.S., Huang, S.S. & Deuel, T.F. Specific covalent binding of platelet-derived growth factor to human plasma α2-macroglobulin. Proc. Natl Acad. Sci. USA 81, 342–346 (1984). (10.1073/pnas.81.2.342) / Proc. Natl Acad. Sci. USA by JS Huang (1984)
  25. Dennis, P.A., Saksela, O., Harpel, P. & Rifkin, D.B. α 2-macroglobulin is a binding protein for basic fibroblast growth factor . J. Biol. Chem. 264, 7210– 7216 (1989). (10.1016/S0021-9258(18)83222-7) / J. Biol. Chem. by PA Dennis (1989)
  26. Orth, K., Madison, E.L., Gething, M.J., Sambrook, J.F. & Herz, J. Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/α2-macroglobulin receptor. Proc. Natl Acad. Sci. USA 89, 7422–7426 (1992). (10.1073/pnas.89.16.7422) / Proc. Natl Acad. Sci. USA by K Orth (1992)
  27. Nykjaer, A. et al. Purified α2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the α2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 267, 14543–14546 (1992). (10.1016/S0021-9258(18)42072-8) / J. Biol. Chem. by A Nykjaer (1992)
  28. Jensen, P.E.H. & Pizzo, S.V. Comparison of α 2-macroglobulin receptors from human, baboon, rat, and mouse liver. Biochem. Arch. 5, 171–176 (1989). / Biochem. Arch. by PEH Jensen (1989)
  29. Maki, R.G., Eddy, R.L., Byers, M., Shows, T.B. & Srivastava, P.K. Mapping of the genes for human endoplasmic reticular HSP gp96/grp94. Somat. Cell Mol. Gen. 19, 73–81 (1993). (10.1007/BF01233956) / Somat. Cell Mol. Gen. by RG Maki (1993)
  30. Hilliker, C., Van Leuven, F. & Van den Berghe, H. Assignment of the gene coding for the α2 -macroglobulin receptor to mouse chromosome 15 and to human chromosome 12q13-q14 by isotopic and non-isotopic in situ hybridization. Genomics 13, 472–474 ( 1992). (10.1016/0888-7543(92)90276-X) / Genomics by C Hilliker (1992)
  31. Basu, S, Binder, R.J., Suto, R., Anderson, K.M. & Srivastava, P.K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. ( 2000) (submitted). (10.1093/intimm/12.11.1539)
  32. Savill, J., Hogg, N., Ren, Y. & Haslett, C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J. Clin. Invest. 90, 1513–1522 (1992). (10.1172/JCI116019) / J. Clin. Invest. by J Savill (1992)
  33. Fadok, V.A. et al. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 85–90 (2000). (10.1038/35011084) / Nature by VA Fadok (2000)
  34. Matzinger, P. An innate sense of danger. Semin Immunol. 10, 399–415 (1998). (10.1006/smim.1998.0143) / Semin Immunol. by P Matzinger (1998)
  35. Srivastava, P.K., DeLeo, A.B. & Old, L.J. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl Acad. Sci. USA 83, 3407–3411 (1986). (10.1073/pnas.83.10.3407) / Proc. Natl Acad. Sci. USA by PK Srivastava (1986)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:45 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:28 p.m.)
Indexed 1 week ago (Aug. 23, 2025, 12:58 a.m.)
Issued 25 years ago (Aug. 1, 2000)
Published 25 years ago (Aug. 1, 2000)
Published Print 25 years ago (Aug. 1, 2000)
Funders 0

None

@article{Binder_2000, title={CD91: a receptor for heat shock protein gp96}, volume={1}, ISSN={1529-2916}, url={http://dx.doi.org/10.1038/77835}, DOI={10.1038/77835}, number={2}, journal={Nature Immunology}, publisher={Springer Science and Business Media LLC}, author={Binder, Robert J. and Han, David K. and Srivastava, Pramod K.}, year={2000}, month=aug, pages={151–155} }